Global Research Finds Long-Term Heart Risks Linked to Severe Bleeding After Birth

Severe postpartum hemorrhage significantly increases women's risk of cardiovascular diseases over the long term, with risks lasting up to 15 years after childbirth, according to a large international study.
A comprehensive international study has revealed that women who experience severe postpartum hemorrhage are at a significantly increased risk of developing cardiovascular diseases over the long term. Analyzing data from over 9.7 million women across Europe, North America, and Asia, researchers found that the health consequences can persist for up to 15 years after childbirth.
Postpartum hemorrhage (PPH), which affects roughly 14 million women annually and accounts for more than 20% of maternal deaths worldwide, has traditionally been viewed as an immediate emergency. However, recent evidence suggests that its effects on blood loss can have lasting impacts on cardiovascular health. The systematic review and meta-analysis encompassed ten studies published up to 2024, with follow-up periods ranging from three to 31 years. The studies included diverse populations from countries such as South Korea, the UK, Sweden, Canada, France, and the US.
Findings indicate that women who suffer severe PPH, especially those requiring blood transfusions, have a 1.76-fold higher risk of cardiovascular conditions like heart failure, stroke, and ischemic heart disease. They are also 2.10 times more likely to experience thromboembolic events like blood clots. The risk is particularly elevated during the first year postpartum but can extend for more than a decade, especially among women with high blood pressure complications like preeclampsia.
Lead researcher Dr. Manggala Pasca Wardhana emphasizes the importance of viewing postpartum care as a continuous process, extending beyond delivery. She suggests that routine cardiovascular screening for women who had severe postpartum bleeding could facilitate early detection and better management of potential health issues.
The research underscores the need for evolving clinical guidelines to include the long-term monitoring of women who experience PPH. It also calls for further research to understand the mechanisms linking severe blood loss at childbirth with cardiovascular diseases and to develop targeted prevention and treatment strategies.
While most data comes from high-income countries, the study highlights the global relevance of addressing PPH’s long-term effects, especially in low- and middle-income countries where PPH prevalence and healthcare access disparities are more pronounced. Recognizing these long-term risks can pave the way for more comprehensive maternal health policies and interventions.
Source: https://medicalxpress.com/news/2025-06-global-links-severe-childbirth-cardiovascular.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
New Findings in Autism Research: Epigenetic Analysis Reveals RABGGTB as a Novel Candidate Gene
A recent study uncovers the gene RABGGTB as a new candidate linked to autism through epigenetic DNA methylation profiling of brain tissue, paving the way for future diagnostic and therapeutic innovations.
Childhood Exposure Near Coldwater Creek in St. Louis Linked to Increased Cancer Risk
Living near Coldwater Creek in St. Louis during childhood has been associated with a higher risk of developing various cancers, highlighting the long-term health impacts of environmental radiation exposure from nuclear waste contamination.
Promising Results from National Trial for Rare Blood Cancer Treatment
Early results from a national clinical trial indicate that a combination therapy may significantly improve outcomes for patients with the challenging blood cancer, CMML, offering new hope for long-term remission.
Targeting Chikungunya Virus with T Cells: New Insights from Immunology Research
Recent research uncovers how T cells respond to specific regions of the Chikungunya virus, paving the way for targeted vaccines and therapies to combat this mosquito-borne disease and its chronic symptoms.



